Continuous Versus Conventional Volume Management During CRRT (Continuous Renal Replacement Therapy)
NCT ID: NCT01405092
Last Updated: 2012-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2010-04-30
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard volume management
patients on this arm will receive usual care volume management during continuous renal replacement therapy
use of continuous renal replacement machine for renal replacement
usual care with volume removal during continuous renal replacement therapy
continuous volume management
use of Critline, Hemametrics USA, in conjunction with continuous renal replacment therapy to determine volume removal
use of continuous renal replacement machine for renal replacement
usual care with volume removal during continuous renal replacement therapy
use of blood volume monitoring device in conjunction with machine used for continuous renal replacement to assess and determine volume removal
blood volume monitoring device, Critline, Hemametric, USA, will be used in conjunction with continuous renal replacement to determine rate of volume removal
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
use of continuous renal replacement machine for renal replacement
usual care with volume removal during continuous renal replacement therapy
use of blood volume monitoring device in conjunction with machine used for continuous renal replacement to assess and determine volume removal
blood volume monitoring device, Critline, Hemametric, USA, will be used in conjunction with continuous renal replacement to determine rate of volume removal
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* not expected to survive 48 hours
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dallas VA Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Devasmita C. Dev MD
Director of In-center and Home Dialysis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dallas VA Medical Center
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
#09-097
Identifier Type: -
Identifier Source: org_study_id